Use of Mannitol Diuresis to Reduce Cisplatin Nephrotoxicity
August 1978
in “
Dicp-The annals of pharmacotherapy
”
mannitol diuresis cis-platinum nephrotoxicity testicular carcinoma prehydration fluid replacement diuresis renal toxicity BUN serum creatinine creatinine clearance electrolyte replacement mannitol cisplatin kidney toxicity testicular cancer hydration fluid therapy urine production kidney damage blood urea nitrogen creatinine kidney function electrolyte balance
Studysummary Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on journals.sagepub.com →